Cyberknife Radiosurgery for Patients With Neurinomas

Launched by FONDAZIONE I.R.C.C.S. ISTITUTO NEUROLOGICO CARLO BESTA · Feb 4, 2014

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a treatment called CyberKnife radiosurgery for patients with sporadic acoustic neuromas, which are usually benign tumors that can affect hearing. The trial aims to compare two different ways of delivering this treatment: a single session or multiple sessions of radiosurgery. The researchers want to see how well these methods preserve hearing, control the growth of the tumor, and what side effects might occur.

To participate in this trial, you must be at least 18 years old, have an acoustic neuroma that is 3 cm or smaller, and still have useful hearing. You will need to provide written consent to join. If you are pregnant, have a specific allergy, or have a condition called neurofibromatosis type 2, you would not be eligible to participate. Those who join the trial can expect close monitoring and support throughout the treatment process, helping to ensure your health and well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Sporadic acoustic neuroma max diameter 3 cm
• • Age: ≥ 18 years old
• • KPS ≥ 70
• • Serviceable hearing (class A and B from the American Academy of Otorhinolaryngology-Head and Neck Surgery classification)
• • Written consent
• Exclusion Criteria:
• • Pregnancy
• • Allergy to contrast medium
• • Neurofibromatosis type 2 (NF2)
• • anacousia